Correlation Between Unicycive Therapeutics and Lyell Immunopharma
Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and Lyell Immunopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and Lyell Immunopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unicycive Therapeutics and Lyell Immunopharma, you can compare the effects of market volatilities on Unicycive Therapeutics and Lyell Immunopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of Lyell Immunopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and Lyell Immunopharma.
Diversification Opportunities for Unicycive Therapeutics and Lyell Immunopharma
-0.62 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Unicycive and Lyell is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and Lyell Immunopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lyell Immunopharma and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with Lyell Immunopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lyell Immunopharma has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and Lyell Immunopharma go up and down completely randomly.
Pair Corralation between Unicycive Therapeutics and Lyell Immunopharma
Given the investment horizon of 90 days Unicycive Therapeutics is expected to generate 1.1 times more return on investment than Lyell Immunopharma. However, Unicycive Therapeutics is 1.1 times more volatile than Lyell Immunopharma. It trades about 0.05 of its potential returns per unit of risk. Lyell Immunopharma is currently generating about -0.03 per unit of risk. If you would invest 52.00 in Unicycive Therapeutics on September 14, 2024 and sell it today you would earn a total of 19.99 from holding Unicycive Therapeutics or generate 38.44% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Unicycive Therapeutics vs. Lyell Immunopharma
Performance |
Timeline |
Unicycive Therapeutics |
Lyell Immunopharma |
Unicycive Therapeutics and Lyell Immunopharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Unicycive Therapeutics and Lyell Immunopharma
The main advantage of trading using opposite Unicycive Therapeutics and Lyell Immunopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, Lyell Immunopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lyell Immunopharma will offset losses from the drop in Lyell Immunopharma's long position.Unicycive Therapeutics vs. Puma Biotechnology | Unicycive Therapeutics vs. Iovance Biotherapeutics | Unicycive Therapeutics vs. Day One Biopharmaceuticals | Unicycive Therapeutics vs. Inozyme Pharma |
Lyell Immunopharma vs. Cullinan Oncology LLC | Lyell Immunopharma vs. Monte Rosa Therapeutics | Lyell Immunopharma vs. Revolution Medicines | Lyell Immunopharma vs. Nkarta Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |